CytoSorbents Corporation
(NASDAQ : CTSO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
ISRGIntuitive Surgical, Inc.
-0.01%984.197.5%$378.64m
MDTMedtronic PLC
-0.02%83.390.6%$348.08m
TMOThermo Fisher Scientific Inc.
0.31%173.101.0%$269.62m
ABTAbbott Laboratories
-0.02%48.730.8%$265.11m
BDXBecton, Dickinson and Company
0.03%197.751.3%$253.86m
ZBHZimmer Biomet Holdings, Inc.
0.61%112.061.7%$186.88m
ALGNAlign Technology, Inc.
0.34%169.196.2%$179.52m
BCRC. R. Bard, Inc.
0.20%318.831.6%$160.96m
SYKStryker Corporation
-0.11%144.141.3%$153.24m
EWEdwards Lifesciences Corporation
0.17%113.301.2%$150.42m
BAXBaxter International Inc.
-0.19%60.761.7%$148.59m
BSXBoston Scientific Corporation
-0.02%26.891.1%$145.75m
HOLXHologic, Inc.
0.24%37.511.6%$140.08m
XRAYDENTSPLY International Inc.
0.06%52.883.0%$113.35m
WATWaters Corporation
0.21%180.083.3%$101.28m

Company Profile

CytoSorbents Corp. is a critical care immunotherapy company, which engages in blood purification to control deadly inflammation in critically-ill and cardiac surgery patients. Its products include cytosorb, contrastsorb, vetresq, hemodefend, and drugsorb. The company was founded by Joseph Rubin on April 25, 2002 and is headquartered in Monmouth Junction, NJ.